BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 27217169)

  • 21. Analytical Performance Validation of Next-Generation Sequencing Based Clinical Microbiology Assays Using a K-mer Analysis Workflow.
    Lepuschitz S; Weinmaier T; Mrazek K; Beisken S; Weinberger J; Posch AE
    Front Microbiol; 2020; 11():1883. PubMed ID: 32849463
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessing the Diversity of Rodent-Borne Viruses: Exploring of High-Throughput Sequencing and Classical Amplification/Sequencing Approaches.
    Drewes S; Straková P; Drexler JF; Jacob J; Ulrich RG
    Adv Virus Res; 2017; 99():61-108. PubMed ID: 29029730
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Guidelines for Sanger sequencing and molecular assay monitoring.
    Crossley BM; Bai J; Glaser A; Maes R; Porter E; Killian ML; Clement T; Toohey-Kurth K
    J Vet Diagn Invest; 2020 Nov; 32(6):767-775. PubMed ID: 32070230
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The reliable assurance of detecting somatic mutations in cancer-related genes by next-generation sequencing: the results of external quality assessment in China.
    Zhang R; Ding J; Han Y; Yi L; Xie J; Yang X; Fan G; Wang G; Hao M; Zhang D; Zhang K; Lin G; Li J
    Oncotarget; 2016 Sep; 7(36):58500-58515. PubMed ID: 27542269
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Korean Society for Genetic Diagnostics Guidelines for Validation of Next-Generation Sequencing-Based Somatic Variant Detection in Hematologic Malignancies.
    Kim H; Yun JW; Lee ST; Kim HJ; Kim SH; Kim JW;
    Ann Lab Med; 2019 Nov; 39(6):515-523. PubMed ID: 31240878
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of machine learning algorithms as integrative tools for validation of next generation sequencing data.
    Marceddu G; Dallavilla T; Guerri G; Zulian A; Marinelli C; Bertelli M
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):8139-8147. PubMed ID: 31599443
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development and preliminary evaluation of a multiplexed amplification and next generation sequencing method for viral hemorrhagic fever diagnostics.
    Brinkmann A; Ergünay K; Radonić A; Kocak Tufan Z; Domingo C; Nitsche A
    PLoS Negl Trop Dis; 2017 Nov; 11(11):e0006075. PubMed ID: 29155823
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systematic Evaluation of Sanger Validation of Next-Generation Sequencing Variants.
    Beck TF; Mullikin JC; ; Biesecker LG
    Clin Chem; 2016 Apr; 62(4):647-54. PubMed ID: 26847218
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Methods in virus diagnostics: from ELISA to next generation sequencing.
    Boonham N; Kreuze J; Winter S; van der Vlugt R; Bergervoet J; Tomlinson J; Mumford R
    Virus Res; 2014 Jun; 186():20-31. PubMed ID: 24361981
    [TBL] [Abstract][Full Text] [Related]  

  • 30. FastqCleaner: an interactive Bioconductor application for quality-control, filtering and trimming of FASTQ files.
    Roser LG; Agüero F; Sánchez DO
    BMC Bioinformatics; 2019 Jun; 20(1):361. PubMed ID: 31253077
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Developmental validation of the MiSeq FGx Forensic Genomics System for Targeted Next Generation Sequencing in Forensic DNA Casework and Database Laboratories.
    Jäger AC; Alvarez ML; Davis CP; Guzmán E; Han Y; Way L; Walichiewicz P; Silva D; Pham N; Caves G; Bruand J; Schlesinger F; Pond SJK; Varlaro J; Stephens KM; Holt CL
    Forensic Sci Int Genet; 2017 May; 28():52-70. PubMed ID: 28171784
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development and analytical validation of a 25-gene next generation sequencing panel that includes the BRCA1 and BRCA2 genes to assess hereditary cancer risk.
    Judkins T; Leclair B; Bowles K; Gutin N; Trost J; McCulloch J; Bhatnagar S; Murray A; Craft J; Wardell B; Bastian M; Mitchell J; Chen J; Tran T; Williams D; Potter J; Jammulapati S; Perry M; Morris B; Roa B; Timms K
    BMC Cancer; 2015 Apr; 15():215. PubMed ID: 25886519
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Practical issues in implementing whole-genome-sequencing in routine diagnostic microbiology.
    Rossen JWA; Friedrich AW; Moran-Gilad J;
    Clin Microbiol Infect; 2018 Apr; 24(4):355-360. PubMed ID: 29117578
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-throughput whole genome sequencing of Porcine reproductive and respiratory syndrome virus from cell culture materials and clinical specimens using next-generation sequencing technology.
    Zhang J; Zheng Y; Xia XQ; Chen Q; Bade SA; Yoon KJ; Harmon KM; Gauger PC; Main RG; Li G
    J Vet Diagn Invest; 2017 Jan; 29(1):41-50. PubMed ID: 28074712
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Survey of point-of-care instrumentation, analysis, and quality assurance in veterinary practice.
    Bell R; Harr K; Rishniw M; Pion P
    Vet Clin Pathol; 2014 Jun; 43(2):185-92. PubMed ID: 24750496
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of the Ion Torrent PGM sequencing workflow for the routine rapid detection of BRCA1 and BRCA2 germline mutations.
    Zanella I; Merola F; Biasiotto G; Archetti S; Spinelli E; Di Lorenzo D
    Exp Mol Pathol; 2017 Apr; 102(2):314-320. PubMed ID: 28263838
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Innovations in the diagnosis of infectious agents of veterinary importance--a seven-league boots fairy tale?].
    Harder TC; Höper D; Beer M
    Berl Munch Tierarztl Wochenschr; 2012; 125(1-2):14-20. PubMed ID: 22372319
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical investigational studies for validation of a next-generation sequencing in vitro diagnostic device for cystic fibrosis testing.
    Grosu DS; Hague L; Chelliserry M; Kruglyak KM; Lenta R; Klotzle B; San J; Goldstein WM; Moturi S; Devers P; Woolworth J; Peters E; Elashoff B; Stoerker J; Wolff DJ; Friedman KJ; Highsmith WE; Lin E; Ong FS
    Expert Rev Mol Diagn; 2014 Jun; 14(5):605-22. PubMed ID: 24844137
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Validation of a next generation sequencing panel for detection of hotspot cancer mutations in a clinical laboratory.
    Shahsiah R; DeKoning J; Samie S; Latifzadeh SZ; Kashi ZM
    Pathol Res Pract; 2017 Feb; 213(2):98-105. PubMed ID: 28049581
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An NGS Workflow Blueprint for DNA Sequencing Data and Its Application in Individualized Molecular Oncology.
    Li J; Batcha AM; Grüning B; Mansmann UR
    Cancer Inform; 2015; 14(Suppl 5):87-107. PubMed ID: 27081306
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.